# A Randomized Controlled Trial on the Efficacy of Tenofovir Disoproxil Fumarate (TDF)-Switch Therapy in Chronic Hepatitis B Patients With Incomplete Response to Entecavir

> **NCT01918631** · NA · COMPLETED · sponsor: **Chinese University of Hong Kong** · enrollment: 36 (actual)

## Conditions studied

- Chronic Heptitis B

## Interventions

- **DRUG:** tenofovir disoproxil fumarate
- **DRUG:** Entecavir

## Key facts

- **NCT ID:** NCT01918631
- **Lead sponsor:** Chinese University of Hong Kong
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2013-08
- **Primary completion:** 2017-01
- **Final completion:** 2017-01-31
- **Target enrollment:** 36 (ACTUAL)
- **Last updated:** 2017-07-19


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01918631

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01918631, "A Randomized Controlled Trial on the Efficacy of Tenofovir Disoproxil Fumarate (TDF)-Switch Therapy in Chronic Hepatitis B Patients With Incomplete Response to Entecavir". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT01918631. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*